Hanson Wade

R&D
3rd Next Generation RNA Therapeutics Summit
Partner Content

3rd Next Generation RNA Therapeutics Summit

Accelerate Next Generation RNAs into Safe & Effective Clinical Candidates with Therapeutic Potentials Across All Diseases by Overcoming Quality, Stability, & Large-Scale Manufacturi

R&D
2nd Medical Device Software Development Europe 2024
Partner Content

2nd Medical Device Software Development Europe 2024

As device developers of all sizes grapple with the updated transition timeline for EU MDR compliance and the recent EU AI Act approval falls short of expectations, the question looms: how can regul

Oncology
8th Tumor Models San Francisco Summit 2024
Partner Content

8th Tumor Models San Francisco Summit 2024

Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic development, and the domino effects across the fie

R&D
5th RNAi-Based Therapeutics Summit
Partner Content

5th RNAi-Based Therapeutics Summit

Despite exciting advancements and new investments into the field, the development of new RNAi therapeutics is plagued by difficulties with extra-hepatic delivery and scale-up of manufacturi